Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

34th Psychiatric Pharmacotherapy Update 2022 - In-Person and Online Broadcast



2022 Live In-Person, Live Online Broadcast and On-Demand CE Conference

Thank you for attending the 24th annual event on October 13-14, 2022!  All sessions have been recorded and will be placed up as on-demand sessions by December 1.

Registrations will be available at Dec 1 to register and view all content on-demand.  If you have already registered, you will have access to all video content by December 1, and until then you may complete evaluations and view the ready on-demand sessions now! 

The University of Texas College of Pharmacy welcomes you to the 34th Psychiatric Pharmacotherapy Update.  This CE activity offers 20+ hours of psychiatric focused continuing education for pharmacists, physicians, advance practice nurses, nurse practitioners, social workers, counselors and psychologists.


TWO WAYS TO ATTEND • ONE REGISTRATION •
THEN FULL ON-DEMAND PROGRAM STARTING IN DECEMBER!

LIVE IN-PERSON in AUSTIN - Join us live in-person at the DoubleTree by Hilton in Austin Texas!  In-person attendees can take advantage of interacting with speakers and a network from colleagues as well as participate in optional BONUS two-hours of CE through our reflection and topic discussion lunches.  In-person attendees have access to the networking reception at the end of day 1.  Come join us in Austin and take advantage of the full program.

LIVE ONLINE BROADCAST - Join us online for the Live Broadcast of the Psychiatric Pharmacotherapy Update!  The broadcast will utilize Zoom Webinar allowing virtual attendees to ask questions of the speakers and participate in topic chats with other attendees. This is a great option for those unable to travel to Austin.  All session will be recorded for later viewing, so you won't miss a thing!

ON-DEMAND VIDEO (starts one month after the Live program) - If you cannot attend live or only part of the live program, know that all sessions will be recorded and available as on-demand video programs to watch anytime in the next year.  All registrants, regardless of attendance type during the live portion will have access to all content on-demand.  In addition to the recordings of the live sessions, additional on-demand sessions will be included to ensure attendees get the content they need for their practice.

 

Registration / Access Content and Evaluations Information:

  1. If you have already registered, click on the log in link at the top right.  This is the same email and password used when you registered.  Log in and from the home page, click the "return to content" button in the program banner to bring you back to this page. 
  2. If not yet registered, there's still time!  Scroll down and click on the "register now" button.  Set up a new ID or log in to your existing account.  Use the "forgot password" feature to retrieve your log on information.
  3. Bookmark this page!  This is the same log on site that will be used during the event for viewing presentation slides, viewing the live broadcasts, access on-demand sessions and access to complete evaluations for CE credit.
For more information, please see the conference full website here.
 

Continuing Education Information: https://sites.utexas.edu/cpe-ppu/agenda/ce-credits/
 

Date: Oct 13, 2022 08:00 AM - Oct 14, 2022 04:30 AM

Fee

$515.00

CE Hours

21.25

CE Units

2.125

Registration closes on Oct 31, 2022 12:00 AM

Activity Type

  • Knowledge

 

 

Registration closes on Oct 31, 2022 at 12:00 AM

Registration Closed  

 
Welcome to the 34th Psychiatric Pharamcotherapy Update
 
 
Live In-Person, Live Online Broadcast, On-Demand Recorded Sessions - One Registration for All!
The 2022 Psychiatric Pharmacotherapy Update offers three ways to attend:
 
  • In-Person - Use this website for information on each live in-person session, check in and meal information, as well as information on the optional lunch CE discussions and the Thursday reception. Click on the tabs below for session information, and look for the "in-person" orange icon to indicate that the tab includes in-person attendees. 
  • Live Online Broadcast - Use this same website for viewing live broadcasts.  Zoom webinar links will be loaded on this page on October 13 and 14 to access the online broadcasts.  Look for the "Live Broadcast" green icons to note which tabs offer the broadcasts.
  • On-Demand - Use this website to access on-demand videos.  There are several on-demand tabs at the bottom of this page where you will be able to access on-demand programs as soon as Oct 13.  All live sessions taking place on October 13 and 14 will be recorded, edited and produced then placed in the live tabs below for on-demand learning.  Allow up to 5 weeks after the conference for the videos to be produced. Look for the dark blue "On-Demand" icons the tabs to note which sessions are ready for on-demand learning.  Note, all on-demand programs will require a post-test.
 

Evaluations for CE Credit
Evaluations: After each live session ends, you can complete the online evaluation for CE credit.  Credits are automatically added to your records as you complete them. 
 
  • Pharmacists:  Your credits will be automatically sent to the NABP profile you entered in your profile for this system.  Please be sure to check the "my profile" link at the top right of this page to ensure your NABP profile and date of birth are correct (the most common errors in credits not loading properly are errors with the profile or date of birth.)
  • All Other Professions: As you complete evaluations the information will be automatically loaded on the downloadable certificate.  To locate the certificate, go to the "View/Print CE Credit" link at the top of this page.  Go to the program title, and you can download a PDF copy of the certificate.  Note, the certificate will continue to add sessions completed as you complete evaluations.  You can come back to download the certificate at any time. 
 

Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
 

Commercial Bias and Disclosures
For each session, note the faculty information in each tab.  Following the faculty title and biography is their commercial interest disclosure statement. 
 
 
Date: 10/13/22
Time: 08:00 AM - 05:15 PM
Registration Closed  

Registration Closed  

 
In-Person Check-In
 
 
Live In-Person: Please check in at the tables as you enter the ballroom area at the DoubleTree
The 2022 Psychiatric Pharmacotherapy Update committe will be welcoming you!  Check in, grab your nametag, grab breakfast and visit the exhibitors
 
 
 
Date: 10/13/22
Time: 07:45 AM - 08:30 AM
Registration Closed  

Registration Closed  

 
Breakfast
 
 
Live In-Person
2022 Psychiatric Pharmacotherapy Update
 
  • Please join us for a light breakfast in the pre-function area and a visit with colleagues
 
 
 
Date: 10/13/22
Time: 07:45 AM - 08:30 AM
Registration Closed  

Registration Closed  

 
34th Psychiatric Pharamcotherapy Update Opening Remarks and Welcome
 
 
Live In-Person & Live Online Broadcast
2022 Psychiatric Pharmacotherapy Update
 
The live broadcast begins as 8:20 with a welcome and opening of the conference along with logistical information on the event format, content, and CE process.
 
 
Date: 10/13/22
Time: 08:20 AM - 08:30 AM
Registration Closed  

Registration Closed  

 
Psychopharmacology Myths and Facts
 
Tawny Smith, Pharm.D., BCPP.
Associate Professor of Psychiatry
The University of Texas at Austin Dell Medical School
 
 
Marisa S. P. Toups, M.D.
Physiatrist / Owner, Singularity Psychiatry and Mental Health
Affiliate Assistant Professor
UT Southwestern Medical School Department of Psychiatry
 
 
LEARNING OBJECTIVES
  • Evaluate the evidence for dose dependent therapeutic effects for lamotrigine and quetiapine
  • Determine if there are dose dependent adverse effects with lamotrigine and quetiapine
  • Examine whether common clinical approaches for on and off label use of lamotrigine and quetiapine are evidenced-based
 
 
ABOUT THE FACULTY

Dr. Tawny Smith: After graduating with her Pharm.D. degree, Dr. Smith completed a psychiatric pharmacy residency and clinical sciences fellowship in mental health outcomes at The University of Texas at Austin College of Pharmacy. She is a board certified psychiatric pharmacist currently serving as an Associate Professor of Psychiatry for The University of Texas at Austin (UT), Dell Medical School.  She also maintains an adjunct faculty appointment with the UT-College of Pharmacy. Dr. Smith has outpatient practices in UT Health Austin Women’s Reproductive Mental Health and Bipolar Disorder clinics at the Mulva Clinic for the Neurosciences.  She also practices at Ascension Seton Shoal Creek Hospital in Austin, where she runs the psychopharmacology consult service. She serves as one of the core faculty for the DMS psychiatry residency program where she has been awarded several teaching awards. She has delivered numerous educational presentations to the community and other health professionals at national and international conferences throughout her career. She has over 80 published abstracts, peer reviewed articles and book chapters in the area of psychiatric pharmacy. She is an active member of the American Association for Psychiatric Pharmacists (AAPP) and finished her 3-year term on the Board of Directors in June 2022. She remains active in her community and most recently she was elected to serve on the Board of Directors for the Austin Clubhouse.

Disclosure: Dr. Smith has no financial relationship(s) to disclose.

 

Dr. Toups is a board-certified psychiatrist, and specialist in treatment resistant depression. After medical school, she completed psychiatric training, including a specialty fellowship focusing on the study of treatment outcomes for Major Depressive Disorder, at UT Southwestern Medical Center in Dallas TX. As faculty at UT Southwestern and UT Austin Dell Medical school she studied the role of immunity in major depression, as well as served as an investigator in numerous clinical trials. She has taught evidence-based medicine to psychiatry residents, is the co-author of an award-winning journal club curriculum, and co-hosts a related podcast, the Yeah, No Journal Club. She now runs her own practice, Singularity Psychiatry and Mental Health, where she provides expert psychiatric care for patients with complex depression.

Disclosure: Dr. Toups has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-115-L01-P
Date: 10/13/22
Time: 08:30 AM - 09:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Autism: An Update on Pharmacologic Management
 
Louisa Keith, M.D.
Assistant Professor, Department of Neurology
The University of Texas at Austin Dell Medical School
 
 
 
LEARNING OBJECTIVES
  • Describe the epidemiology and diagnosis of Autism Spectrum Disorder (ASD).
  • Describe approach to symptom management in children with ASD.
  • Identify indications for pharmacological management of symptoms in ASD and briefly describe uses and limitations of commonly prescribed medications.
 
 
ABOUT THE FACULTY

Louisa Keith, MD, is a pediatric neurologist in UT Health Austin Pediatric Neurosciences at Dell Children’s, a clinical partnership between Dell Children’s Medical Center and UT Health Austin. She specializes in general child neurology. Additionally, Dr. Keith is an assistant professor in the Dell Medical School Department of Neurology.  Dr. Keith earned her medical degree from Drexel University College of Medicine and her bachelor’s from Harvard University. She completed both an internship and residency in pediatrics at Mount Sinai Kravis Children’s Hospital as well as a residency in child neurology at Boston Children’s Hospital.  Dr. Keith’s clinical interests include the neurodevelopmental outcomes of children with congenital heart disease. She leads the cardiac follow-up program within the neurodevelopmental program at Dell Children’s Medical Center.  Dr. Keith is a pediatric neurologist with UT Health Austin.


Disclosure: Dr. Keith does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 
 

Activity Number

0067-0000-22-116-L01-P
Date: 10/13/22
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Break
 
 
2022 Psychiatric Pharmacotherapy Update
 
  • In-person attendees may enjoy a light refershment break in the pre-function area. 
  • For online broadcast attndees, please enjoy the break and note the next session will begin soon on the same Zoom link as the earlier sessions. 
 
 
 
Date: 10/13/22
Time: 09:30 AM - 09:45 AM
Registration Closed  

Registration Closed  

 
Management of Serious Mental Illness and Intellectual Developmental Disabilities
 
Stella J Logan, MSN, PMHCNS-BC, PMHNP-BC
Psychiatric-Mental Health Clinical Nurse Specialist and Nurse Practitioner
Psychiatric Associates of Central Texas
 
 
 
 
LEARNING OBJECTIVES
  • Discuss some of the diagnostic challenges in treating patients with Serious Mental Illness and Intellectual Developmental Disabilities
  • Discuss barriers of care in treatment for patients with SMI and IDD including diagnosis, socioeconomic issues, and resource allocation.
  • Review select treatment options and outcomes for common problems in patients with SMI and IDD.
 
 
ABOUT THE FACULTY

Stella Logan graduated with her BSN from the University of Cincinnati.  After working as an ICU nurse, she went on to obtain her MSN with clinical specialty in psychiatric-mental health nursing from Case Western Reserve University in Cleveland Ohio.  She worked as a Clinical Nurse Specialist in a variety of inpatient, outpatient, private and public facilities in Ohio, Indiana and Oregon, and served on the faculty at Oregon Health Sciences University School of Nursing.  She moved to Texas in 1991, and after working in school health joined the faculty at the University of Texas at Austin School of Nursing.  She obtained a post-masters certificate as a FPMHNP from the University of Texas at Arlington after which she was instrumental in the development of the UT Austin PMHNP program.  She continues to serve as an affiliate faculty at UT Austin School of Nursing, has a clinical practice focusing on people with serious mental illness and intellectual disabilities, and maintains involvement in various professional organizations at the local, state, and national levels.

Disclosure: Stella Logan has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-117-L01-P
Date: 10/13/22
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Is Psychedelic Psychiatry Really Going to Change Care?
 
Greg Fonzo, PhD
Assistant Professor and Co-Director
Center for Psychedelic Research and Therapy
Department of Psychiatry and Behavioral Sciences
The University of Texas at Austin Dell Medical School
 
 
 
 
LEARNING OBJECTIVES
  • Identify factors that differentiate psychedelic-assisted therapies from other evidence-based approaches
  • Discuss/update on psilocybin-assisted psychotherapy
  • Discuss/update on MDMA-assisted psychotherapy.
  • Identify key areas for further development in optimizing and disseminating this novel approach
 
 
ABOUT THE FACULTY

Greg Fonzo, Ph.D., is an Assistant Professor and Co-Director of the Center for Psychedelic Research and Therapy in the Department of Psychiatry and Behavioral Sciences at The University of Texas at Austin Dell Medical School.  He completed his Ph.D. in Clinical Psychology at the San Diego State University/University of California-San Diego Joint Doctoral Program.  He completed his postdoctoral fellowship in bio-behavioral research at the Stanford University School of Medicine.  Dr. Fonzo’s research encompasses two main themes.  First, his laboratory utilizes non-invasive neuroscience tools such as neuroimaging and neuromodulatory probes to understand neurobiological mechanisms of stress-related mental health disorders such as posttraumatic stress disorder, anxiety, and major depression.  Second, his laboratory is focused on designing novel neuroscience-informed interventions to alleviate mental health symptoms, with a particular focus on psychedelic-assisted therapies and neuromodulation. In his clinical practice, he specializes in the assessment and evidence-based psychotherapeutic treatment of posttraumatic stress disorder, anxiety, and depression.

Disclosure: Dr. Fonzo has no financial relationship(s) to disclose.

 

 
 

Activity Number

0067-0000-22-118-L04-P
Date: 10/13/22
Time: 11:45 AM - 12:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Lunch Break
 
 
Live In-Person: Lunch will be availalbe for in-person attendees in the pre-function area
 
Online Broadcast attendees, know there is a 1:15 hour break.  The program will resume on the same Zoom webinar link at 2pm.
 
 
 
Date: 10/13/22
Time: 12:45 PM - 02:00 PM
Registration Closed  

Registration Closed  

 
Lunch: BONUS CE Session: Treatment Share Discussion
 
Glen Baumgart, PhD
Director of Continuing Professional Development
The University of Texas at Austin College of Pharmacy
 
 
 
 
LEARNING OBJECTIVES
  • Discuss morning topic presentations with specific discussion about changes in treatment approach
  • Discuss case studies on morning treatment update topics
  • Identify one change in current practice approach that may be utilize upon return to practice
 
 
ABOUT LUNCH SESSION

This optional lunch CE session for in-person attendees includes guided table discussions about topic and treatment changes based on morning topics.  Participants may choose a table based on the topic where set questions will be asked and responses discussed focused on the treatment changes and new information learned from previous lectures.  Based on topic, case studies will be introduced for discussion.  At the close, participants will complete the online assessment asking to summarize what was gained for them through the discussion and to identify one change likely to be made in practice based on the lessons and discussion.

Topic discussions following CE lecture sessions have been shown to significantly increase learner understanding of the presented content and more likely to result in implementation of new practices in patient care. 


This is an optional CE program for in-person attendees.  In-person attendees may choose to skip the discussions and sit at alternate tables for a networking lunch.  Only participants at the designated discussion tables will be eligible for CE credit. 

Facilitator: Glen Baumgart, PhD serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy.  He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions.  Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.

 

 
 

Activity Number

0067-0000-22-119-L01-P
Date: 10/13/22
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Update on Treatment of Bipolar Disorder in Children and Adolescents
 
Karen Dineen Wagner, MD, PhD
Professor and Chair, Department of Psychiatry and Behavioral Sciences
Harry K. Davis Professor, University of Texas Medical Branch
 
 
 
 
LEARNING OBJECTIVES
 
  • Review the clinical features of bipolar disorder in youth.
  • Discuss the evidence base for the pharmacotherapy of bipolar disorder in children and adolescents.
  • Review the safety profile of medication for the treatment of bipolar disorder in youth.
 
ABOUT THE FACULTY
 
Karen Dineen Wagner, M.D., Ph.D., is Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical Branch in Galveston. She is Past President of the American Academy of Child and Adolescent Psychiatry and current President of the Texas Society of Psychiatric Physicians.  Dr. Wagner is an internationally recognized expert in the pharmacological treatment of childhood mood disorders. Her work has contributed to the development of evidence-based treatments for children and adolescents with major depression and bipolar disorder.

Disclosure: Dr. Wagner has no financial relationship(s) to disclose.

 

 
 

Activity Number

0067-0000-22-120-L01-P
Date: 10/13/22
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Break
 
 
2022 Psychiatric Pharmacotherapy Update
 
  • In-person attendees may enjoy a light refershment break in the pre-function area. 
  • For online broadcast attndees, please enjoy the break and note the next session will begin soon on the same Zoom link as the earlier sessions. 
 
 
 
Date: 10/13/22
Time: 03:00 PM - 03:15 PM
Registration Closed  

Registration Closed  

 
Substance Use Disorder Update
 
Amanda Simonton, PhD, APRN, PMHNP-BC
Clinical Assistant Professor
The University of Texas at Austin School of Nursing
 
 
 
 
LEARNING OBJECTIVES
  • Describe updates to prevalence rates in SUDs and overdose death rates
  • Review medications available for SUDs and possible future treatment options
  • Discuss the buprenorphine waiver, how the waiver is obtained, and the waiver exemption
 
ABOUT THE FACULTY
 

Amanda J. Simonton, PhD, APRN, PMHNP-BC is a Clinical Assistant Professor at the University of Texas at Austin School of Nursing and Psychiatric Mental Health Nurse Practitioner at the Texas Child Study Center at Dell Children’s Medical Center. She has been a Registered Nurse since 2013 and previously worked in the Intermediate Care Unit at Seton Medical Center Austin and Psychiatric Emergency Department at University Medical Center Brackenridge. As a psychiatric nurse practitioner, she has primarily worked with adults with dual-diagnosed (substance use and mental health) disorders and with children and adolescents. She earned her Bachelor of Science in Nursing (’13), Master of Science in Nursing (’18), and Doctor of Philosophy (’20) through the School of Nursing at the University of Texas at Austin. She is active in presenting at the annual conferences for Texas Nurse Practitioners and the American Psychiatric Nurses Association. She is currently on the Policy Council for Texas Nurse Practitioners and the President-Elect on the American Psychiatric Nurses Association Texas Chapter Board of Directors. Dr. Simonton is also a member of two steering committees, which focus on treatment of schizophrenia spectrum disorders and bipolar depression, for Medscape Inc. Her research and clinical interests are to improve the lives of individuals with substance use disorders and serious mental illness by utilizing evidence-based care and best-practices in the field of psychiatry and psychology.

Disclosure: Dr. Simonton has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

–Medscape Inc. (ongoing)
–Takeda Pharmaceuticals (completed 9/2022)
–Alkermes Inc (completed 9/2021)
- Corium Inc (completed 7/2021)
 
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
 
 

Activity Number

0067-0000-22-121-L01-P
Date: 10/13/22
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Psychotropic New Drug Update
 
Stephen R. Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program
Clinical Professor
The University of Texas at Austin College of Pharmacy
 
 
 
 
LEARNING OBJECTIVES
  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.
 
ABOUT THE FACULTY
 

Dr. Saklad was born in Los Angeles, California in 1953, and graduated from Pacific Palisades High School in 1970. He received his baccalaureate degree cum laude in Bacteriology from the University of California, Los Angeles in 1974. His Doctor of Pharmacy degree was earned at the University of Southern California in 1978. He had a National Institute of Mental Health training fellowship in Psychiatric Pharmacy supervised by Jim Wilson, Pharm.D., BCPP at the Nebraska Psychiatric Institute of the University of Nebraska Medical Center at Omaha in 1978-9. He then joined the faculty of The University of Texas at Austin College of Pharmacy and the clinical staff at San Antonio State Hospital (SASH) in 1979. He was the first clinical pharmacist employed by the Texas Department of Mental Health and Mental Retardation (now Texas Health and Human Services) when he began as Clinical Coordinator at SASH. He has lived in San Antonio, Texas since 1979. He is married and the father of triplet sons.

During his 38 years career, Dr. Saklad has provided clinical care, education, and research in a variety of settings and treatment roles at SASH. He team teaches didactic courses for second and third professional year pharmacy students. He is the course director for Advanced Pharmacotherapy Laboratory, a third professional year opportunity for students to develop their clinical presentation skills that is given across four campuses. He precepts and mentors third and fourth professional year pharmacy students (P3’s & P4’s) at SASH. He received the UT Austin College of Pharmacy’s Teaching Award from the Class of 2014. He authored and successfully discussed with members of the Texas Legislature the creation of a clinical research unit at SASH that was funded by the Texas Legislature and jointly governed by the UT Austin College of Pharmacy, UT Health Science Center San Antonio Department of Psychiatry and SASH.

Dr. Saklad initiated and developed the first websites for the UT Austin College of Pharmacy in 1994, the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997, and the CPNP Foundation in 2015. He helped to design, organize and was a founding member of CPNP when it incorporated in 1998 as well as the CPNP Foundation in 2012. In 2003, he was elected to the Board of Directors of the CPNP for a two-year term. He has served as a member or officer of the CPNP Communications Committee since the creation of CPNP from 1995 to 2011 and was the Founding Senior Editor of the Mental Health Clinician, CPNP’s Open Access journal, from 2011-13. Currently, Dr. Saklad is Treasurer of the CPNP Foundation a member of the CPNP Business Development Committee. He was on the task force that developed The Mental Health Pharmacy Directory to improve patient access. He is the Director of The University of Texas Psychiatric Pharmacy Program. In 1988, he helped to create and has chaired The University of Texas at Austin College of Pharmacy’s Psychiatric Pharmacotherapy Update since 2007.

Dr. Saklad publishes articles and presents to many groups around the country on a variety of pharmacy and mental health-related topics. He edited Psychopharmacology Update newsletter from 1998-2002 and edited two editions of a compendium based upon this newsletter, Psychopharmacology Desktop Reference, published by Manisses Communications Group in 1999 and 2002. He provides updates on his Twitter feed on a variety of topics @pharmacopsych.

Dr. Saklad is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, depression, and other serious and persistent mental illness, as well as their pharmacokinetics and interactions. He was the Director of UT Health Science Center San Antonio’s Advanced Pharmacotherapy Research with research facilities located at Laurel Ridge Treatment Center and President of Alamo Superior Research, LLC. He has been affiliated with the Behavioral Wellness (“Be Well”) Center, Department of Psychiatry, UT Health San Antonio since 2009.


Disclosure: Dr. Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

Employee of Texas Department of Health Services San Antonio
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otsuka, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio
 
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
 
 

Activity Number

0067-0000-22-122-L01-P
Date: 10/13/22
Time: 04:15 PM - 05:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Day 1 Concludes
 
 
Live In-Person & Live Online Broadcast
2022 Psychiatric Pharmacotherapy Update
 
  • Thank you for attending the first day of the program. 
  • Note Online Broadcast Viewers - the second day will have a new Zoom webinar link. 
  • All evaluations for CE credit for Day 1 are now available.  Please complete evaluations within 7 days to ensure Live credit
 
 
 
Date: 10/13/22
Time: 05:15 PM - 05:15 PM
Registration Closed  

Registration Closed  

 
Reception
 
 
Live In-Person
2022 Psychiatric Pharmacotherapy Update
 
  • Please join us for a reception in the hotel lobby to meet and connect with colleagues
 
 
 
Date: 10/13/22
Time: 05:15 PM - 06:30 PM
Registration Closed  

Registration closes on Oct 31, 2022 at 12:00 AM

Registration Closed  

 
Welcome to the 34th Psychiatric Pharamcotherapy Update
 
 
Live In-Person, Live Online Broadcast, On-Demand Recorded Sessions - One Registration for All!
The 2022 Psychiatric Pharmacotherapy Update offers three ways to attend:
 
  • In-Person - Use this website for information on each live in-person session, check in and meal information, as well as information on the optional lunch CE discussions and the Thursday reception. Click on the tabs below for session information, and look for the "in-person" orange icon to indicate that the tab includes in-person attendees. 
  • Live Online Broadcast - Use this same website for viewing live broadcasts.  Zoom webinar links will be loaded on this page on October 13 and 14 to access the online broadcasts.  Look for the "Live Broadcast" green icons to note which tabs offer the broadcasts.
  • On-Demand - Use this website to access on-demand videos.  There are several on-demand tabs at the bottom of this page where you will be able to access on-demand programs as soon as Oct 13.  All live sessions taking place on October 13 and 14 will be recorded, edited and produced then placed in the live tabs below for on-demand learning.  Allow up to 5 weeks after the conference for the videos to be produced. Look for the dark blue "On-Demand" icons the tabs to note which sessions are ready for on-demand learning.  Note, all on-demand programs will require a post-test.
 

Evaluations for CE Credit
Evaluations: After each live session ends, you can complete the online evaluation for CE credit.  Credits are automatically added to your records as you complete them. 
 
  • Pharmacists:  Your credits will be automatically sent to the NABP profile you entered in your profile for this system.  Please be sure to check the "my profile" link at the top right of this page to ensure your NABP profile and date of birth are correct (the most common errors in credits not loading properly are errors with the profile or date of birth.)
  • All Other Professions: As you complete evaluations the information will be automatically loaded on the downloadable certificate.  To locate the certificate, go to the "View/Print CE Credit" link at the top of this page.  Go to the program title, and you can download a PDF copy of the certificate.  Note, the certificate will continue to add sessions compelted as you complete evaluations.  You can come back to download the certificate at any time. 
 

Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
 

Commercial Bias and Disclosures
For each session, note the faculty information in each tab.  Following the faculty title and biography is their commercial interest disclosure statement. 
 
 
Date: 10/14/22
Time: 08:00 AM - 04:15 PM
Registration Closed  

Registration Closed  

 
In-Person Check-In
 
 
Live In-Person: Please check in at the tables as you enter the ballroom area at the DoubleTree
The 2022 Psychiatric Pharmacotherapy Update committe will be welcoming you!  No need to check in if you attended Thursday.  Pleasee grab breakfast and visit the exhibitors
 
 
 
Date: 10/14/22
Time: 07:45 AM - 08:30 PM
Registration Closed  

Registration Closed  

 
Breakfast
 
 
Live In-Person
2022 Psychiatric Pharmacotherapy Update
 
  • Please join us for a light breakfast in the pre-function area and a visit with colleagues
 
 
 
Date: 10/14/22
Time: 07:45 AM - 08:30 PM
Registration Closed  

Registration Closed  

 
34th Psychiatric Pharamcotherapy Update Opening Remarks
 
 
Live In-Person & Live Online Broadcast
2022 Psychiatric Pharmacotherapy Update
 
The live broadcast begins as 8:20 with a welcome and opening of the conference along with logistical information on the event format, content, and CE process.
 
 
Date: 10/14/22
Time: 08:20 AM - 08:30 AM
Registration Closed  

Registration Closed  

 
Complementary and Integrative Health (CIH) Update
 
Claudia Voyles, DAOM, LAc
WH&IHS Acupuncturist
CTVHSC, Karisha ONE
Remedy Center for Healing Arts, Inc.
 
 
 
LEARNING OBJECTIVES
  • Explore the complementary and integrative health (CIH) promising practices in the Veterans Health Administration (VHA) and the Whole Health model.
  • Describe evidence-supported, government-approved CIH modalities.
  • Discuss recommendations on integration of CIH modalities – tools for healthcare professionals and for patient/participant self-care.
 
ABOUT THE FACULTY
 
Claudia Voyles, DAOM, LAc loves needles!  Claudia is a licensed acupuncturist for the Veterans Health Administration (VHA) and Karisha ONE, Health, Medicine and Wellness in Austin, Texas. She obtained her BA in Psychology from Yale University and worked in the behavioral health field for many years in clinical and administrative roles. In 1991, she trained as an Acupuncture Detoxification Specialist (ADS) at Lincoln Recovery Center in the South Bronx and became one of the first official Registered Trainers for the National Acupuncture Detoxification Association (NADA) in 1997. Providing the NADA protocol in behavioral health settings led her to deeper study of Traditional East Asian Medicine (TEAM) at the Oregon College of Oriental Medicine and subsequently her doctoral degree at the AOMA Graduate School of Integrative Medicine where she remains on faculty. She ran a private practice and integrated healing arts center for 20 years. For the VA, Claudia provides individual and group acupuncture for up to 94 Veterans/week as well as offering classes in TEAM and Qigong. She serves as co-chair of an interdisciplinary committee working to improve Veteran access to Complementary & Integrative Health (CIH) modalities. 
 
Claudia is not officially representing the VHA today. Her views are her own and do not necessarily reflect those of the VHA.

Disclosure: Claudia Voyles has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-123-L04-P
Date: 10/14/22
Time: 08:30 AM - 09:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Update on Treatment Resistant Depression in Adults
 
Marisa S. P. Toups, M.D.
Psychiatrist / Owner, Singularity Psychiatry and Mental Health
Affiliate Assistant Professor
UT Southwestern Medical School Department of Psychiatry
 
Nicholas Ortiz, M.D.
Assistant Professor of Psychiatry
The University of Texas at Austin Dell Medical School
 
 
 
 
LEARNING OBJECTIVES
  • Review expert consensus on TRD definition and placement of new therapies in treatment algorithms
  • Discuss new treatments in development impacting Glutamate/GABA neurophysiology
  • Discuss relevant differences between TMS treatment protocols that inform their use in TRD patients
 
ABOUT THE FACULTY

Dr. Toups is a board-certified psychiatrist, and specialist in treatment resistant depression. After medical school, she completed psychiatric training, including a specialty fellowship focusing on the study of treatment outcomes for Major Depressive Disorder, at UT Southwestern Medical Center in Dallas TX. As faculty at UT Southwestern and UT Austin Dell Medical school she studied the role of immunity in major depression, as well as served as an investigator in numerous clinical trials. She has taught evidence-based medicine to psychiatry residents, is the co-author of an award-winning journal club curriculum, and co-hosts a related podcast, the Yeah, No Journal Club. She now runs her own practice, Singularity Psychiatry and Mental Health, where she provides expert psychiatric care for patients with complex depression.

Disclosure: Dr. Toups has no financial relationship(s) to disclose.


Nicholas Ortiz, MD, is a board-certified psychiatrist in UT Health Austin’s Mulva Clinic for the Neurosciences. Additionally, Dr. Ortiz is an assistant professor in the Dell Medical School Department of Psychiatry. He serves on the Medical Executive Council for Ascension Seton Shoal Creek and as the Clinical Director of Electroconvulsive Therapy (ECT) for Ascension Seton Medical Center. Dr. Ortiz is also the clinical director of Transcranial Magnetic Stimulation (TMS) for UT Health Austin. Dr. Ortiz completed a residency in psychiatry at The University of Texas at Austin Dell Medical School. He received his medical degree from The University of Texas Health Science Center San Antonio and earned his bachelor’s in science from Southwestern University. Dr. Ortiz’s clinical interests include Neurostimulation, Major Depressive Disorder, Bipolar Disorder, and inpatient psychiatry. He is a prolific instructor at Dell Med and also participates in research and publications.

Disclosure: Dr. Ortiz has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-124-L01-P
Date: 10/14/22
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Break
 
 
2022 Psychiatric Pharmacotherapy Update
 
  • In-person attendees may enjoy a light refershment break in the pre-function area. 
  • For online broadcast attndees, please enjoy the break and note the next session will begin soon on the same Zoom link as the earlier sessions. 
 
 
 
Date: 10/14/22
Time: 10:30 AM - 10:45 AM
Registration Closed  

Registration Closed  

 
Clinical Controversies in Catatonia
 
Mark Messer, D.O.
Superintendent and Medical Director
Terrell State Hospital
Health & Specialty Care System/Texas Health and Human Services
 
 
 
 
LEARNING OBJECTIVES
  • Recognize symptoms, common rating scales, and complications of catatonia
  • Examine the role of pharmacotherapy and ECT in catatonia,
  • Compare and contrast the evidence to support novel treatment strategies for the management of catatonia.
  • Develop a treatment plan for someone with the diagnosis of catatonia.
 
ABOUT THE FACULTY

Dr. Mark Messer is a is a board-certified psychiatrist who has been practicing psychiatry for 24 years and has been dedicated to the community with extensive experience in public and private inpatient and outpatient settings, including, but not limited to, forensic, child and adolescent, clinical research, and at present three academic faculty appointments.  He is an experienced psychiatric director who continues to actively participate in the treatment of the seriously mentally ill and dually diagnosed patients. Dr. Messer is currently the CEO and Medical Director at Terrell State Hospital, a 305 bed inpatient psychiatric facility.


Disclosure: Dr. Messer does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

 
 

Activity Number

0067-0000-22-125-L01-P
Date: 10/14/22
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Lunch Break
 
 
Live In-Person: Lunch will be availalbe for in-person attendees in the pre-function area
 
Online Broadcast attendees, know there is a 1:15 hour break.  The program will resume on the same Zoom webinar link at 1pm.
 
 
 
Date: 10/14/22
Time: 11:45 AM - 01:00 PM
Registration Closed  

Registration Closed  

 
Lunch: BONUS CE Session: Treatment Share Discussion
 
Glen Baumgart, PhD
Director of Continuing Professional Development
The University of Texas at Austin College of Pharmacy
 
 
 
 
LEARNING OBJECTIVES
  • Discuss morning topic presentations with specific discussion about changes in treatment approach
  • Discuss case studies on morning treatment update topics
  • Identify one change in current practice approach that may be utilize upon return to practice
 
 
ABOUT LUNCH SESSION

This optional lunch CE session for in-person attendees includes guided table discussions about topic and treatment changes based on morning topics.  Participants may choose a table based on the topic where set questions will be asked and responses discussed focused on the treatment changes and new information learned from previous lectures.  Based on topic, case studies will be introduced for discussion.  At the close, participants will complete the online assessment asking to summarize what was gained for them through the discussion and to identify one change likely to be made in practice based on the lessons and discussion.

Topic discussions following CE lecture sessions have been shown to significantly increase learner understanding of the presented content and more likely to result in implementation of new practices in patient care. 


This is an optional CE program for in-person attendees.  In-person attendees may choose to skip the discussions and sit at alternate tables for a networking lunch.  Only participants at the designated discussion tables will be eligible for CE credit. 

Facilitator: Glen Baumgart, PhD serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy.  He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions.  Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.

 

 
 

Activity Number

0067-0000-22-126-L01-P
Date: 10/14/22
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Treatment Update on Obsessive Compulsive Disorder
 
Samantha Catanzano, PharmD, BCPP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 
 
 
 
LEARNING OBJECTIVES
  • Review key characteristics and pathophysiology of OCD
  • Discuss evidence-based pharmacological treatments for OCD
  • Discuss treatment approaches for patients with OCD and comorbid mental health conditions
 
ABOUT THE FACULTY
 
After graduating with her Pharm.D. degree from the University of Texas at Austin, Dr. Catanzano completed a pharmacy practice residency followed by a psychiatric pharmacy practice residency at Seton Healthcare Family and The University of Texas at Austin College of Pharmacy. Following her residency training, she gained experience as a clinical and staff pharmacist at the Austin State Hospital. Currently, she serves as a Clinical Assistant Professor for The University of Texas at Austin College of Pharmacy. She also provides academic lectures to first- and second-year psychiatry residents and addiction medicine fellows through Dell Medical School’s department of psychiatry. In addition to her academic appointment, she is a Psychiatric Pharmacist at UT Health Austin within the Integrated Behavioral Health Department where she serves the Primary Care, Musculoskeletal, Post-COVID-19 Program, and Multiple Sclerosis clinics. In this role, she functions as part of a multidisciplinary team to address complex pharmacology and mental health needs in the community setting. Additionally, she is a certified Mental Health First Aid instructor and is an active leader within the American Association of Psychiatric Pharmacists (AAPP).

Disclosure: Dr. Catanzano has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-127-L01-P
Date: 10/14/22
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Break
 
 
2022 Psychiatric Pharmacotherapy Update
 
  • In-person attendees may enjoy a light refershment break in the pre-function area. 
  • For online broadcast attndees, please enjoy the break and note the next session will begin soon on the same Zoom link as the earlier sessions. 
 
 
 
Date: 10/14/22
Time: 01:00 PM - 01:15 PM
Registration Closed  

Registration Closed  

 
RAISE Your Communication: Elevating and Updating Your Clinical Language
 
K. Ashley Garling Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
President Capital Area Pharmacist Association
 
Morgan P. Stewart, PharmD, BCACP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 
 
 
 
LEARNING OBJECTIVES
  • Describe the “RAISE” acronym (Recognition, Awareness, Inclusivity, Stigma, Educated decisions) for elevating communication
  • Describe communication skills that create open, receptive, and honest encounters
  • Discuss using non-stigmatized and inclusive language
  • Demonstrate making educated language decisions that address common situations in healthcare
 
ABOUT THE FACULTY
 

Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning from telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.

Disclosure: Dr. Garling has no financial relationship(s) to disclose.


Morgan Stewart is a Clinical Assistant Professor in the Division of Pharmacy Practice at the University of Texas at Austin College of Pharmacy (UTCOP). Dr. Stewart received her Doctor of Pharmacy degree from the University of Houston College of Pharmacy. She completed a Postgraduate Year One (PGY1) Pharmacy Residency at The Ohio State University, followed by a PGY2 Ambulatory Care Residency at the University of Colorado. Dr. Stewart is a board-certified ambulatory care pharmacist (BCACP), board-certified in advanced diabetes management (BC-ADM), and practices as a clinical pharmacist at CommUnityCare Federally Qualified Health Centers in Austin, Texas. Her academic activities at UTCOP include teaching in various pharmacotherapy and elective modules on ambulatory care and diabetes-related topics as week as precepting pharmacy students for both introductory and advanced pharmacy practice experiences at her clinic. She is involved in many professional organizations including APhA, AACP, and TSHP.

Disclosure: Dr. Stewart has no financial relationship(s) to disclose.

 
 

Activity Number

0067-0000-22-129-L04-P
Date: 10/14/22
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Antipsychotics in Pregnancy and Lactation - POSTPONED
 
Jeffrey Newport, M.D.
Director of Women’s Reproductive Mental Health
UT Health Austin
 
 
 
 
Due to illness, this session has been postponed.  The session will be recorded and made availalbe as an on-demand session as soon as possible.
 
LEARNING OBJECTIVES
  • Recognize the factors that contribute to antipsychotic prescribing during pregnancy and lactation
  • Describe the pharmacokinetic profiles of antipsychotics, their determinants and clinical implications
  • Describe the data regarding the gestational and infant outcomes associated with antipsychotic exposure
  • Apply knowledge regarding perinatal exposure to antipsychotics to sound clinical decision-making
 
ABOUT THE FACULTY
 

Jeffrey Newport is Professor of Psychiatry and Women’s Health at the University of Texas at Austin Dell Medical School where he serves as Associate Chair for Research for the Department of Psychiatry & Behavioral Sciences and Director of Texas Women’s Reproductive Mental Health.. Dr. Newport completed a graduate theological degree before receiving his medical degree from the University of South Carolina. He subsequently completed psychiatric residency and a master’s degree in clinical research at Emory University. His awards include the NARSAD Independent and Young Investigator Awards, Young Faculty Award from the American Psychiatric Institute for Research and Education, the Society of Biological Psychiatry’s Lilly Fellowship, the American College of Psychiatrists’ Laughlin Fellowship, and the Distinguished Physician Alumnus Award from the University of South Carolina. He has published in leading journals across numerous specialties including JAMA, American Journal of Psychiatry, American Journal of Obstetrics & Gynecology, Neurology, and Pediatrics. Dr. Newport’s research focuses on women’s mental health with an emphasis on the psychobiology of perinatal psychiatric disorders, psychotropic pharmacokinetics during pregnancy and lactation, and the persistent biobehavioral impact of childhood trauma and other early life adverse experiences.


Disclosure: Dr. Newport has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

  • Grant/Research Support: Eli Lilly, Glaxo Smith Kline, Janssen, Sage Therapeutics, Takeda Pharmaceuticals, Wyeth
  • Honorarium: Astra-Zeneca, Glaxo Smith Kline, Janssen, Sage Therapeutics, Takeda Pharmaceuticals, Wyeth
 
 

Activity Number

0067-0000-22-128-L01-P
Date: 10/14/22
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

 
Overall Conference Evaluation
 
 
 
All Attendees
The 2022 Psychiatric Pharmacotherapy Update committee would like to thank you for participating in this year's event.  We ask that you please complete the overall evaluation to help provide feedback on this year's event and help us in planning next year.
 
 
 
Date: 10/14/22
Time: 12:00 PM - 12:00 PM
Registration Closed  

Registration Closed  

 
Day 2 Concludes • Conference Adjourns
 
 
Live In-Person & Live Online Broadcast
2022 Psychiatric Pharmacotherapy Update
 
  • Thank you for attending the our conference. 
  • Please take a moment to complete our overall evaluation
  • All evaluations for CE credit for Day 2 are now available.  Please complete evaluations within 7 days to ensure Live credit
 
 
 
Date: 10/14/22
Time: 04:15 PM - 04:15 PM
Registration Closed  

Registration Closed  

 
On-Demand Sessions Start Here
 
 
The 2022 Psychiatric Pharmacotherapy Update offers additional On-Demand programming to provide learners with additional topics to help their practice.
The 2022 Psychiatric Pharmacotherapy Update On-Demand sessions start in the below tabs.
 
On-Demand Instructions
  1. Select the topic you would like to complete
  2. View the full video
  3. Complete the online test / assessment
  4. Complete the online evaluation for CE credit
 

Evaluations for CE Credit
Evaluations: After each live session ends, you can complete the online evaluation for CE credit.  Credits are automatically added to your records as you complete them. 
 
  • Pharmacists:  Your credits will be automatically sent to the NABP profile you entered in your profile for this system.  Please be sure to check the "my profile" link at the top right of this page to ensure your NABP profile and date of birth are correct (the most common errors in credits not loading properly are errors with the profile or date of birth.)
  • All Other Professions: As you complete evaluations the information will be automatically loaded on the downloadable certificate.  To locate the certificate, go to the "View/Print CE Credit" link at the top of this page.  Go to the program title, and you can download a PDF copy of the certificate.  Note, the certificate will continue to add sessions completed as you complete evaluations.  You can come back to download the certificate at any time. 
 
 

Registration Closed  

Registration Closed  

TxCOPE: What is TxCOPE and How Can it Help Your Organization

 
Kasey Claborn, PhD
Assistant Professor of Psychiatry
The University of Texas at Austin School of Social Work
 
 
This project is funded in part by Texas Health & Human Services Texas Targeted Opioid Response
 
LEARNING OBJECTIVES
  • Describe what Texas Connecting Overdose Prevention Efforts (TxCOPE) is and how it will improve overdose prevention efforts across Texas
  • Discuss the co-design process between community and academic partners to develop TxCOPE
  • Identify how TxCOPE can be used in your organization
 
ABOUT THE FACULTY
 
Kasey Claborn, PhD is a research scientist and clinical psychologist at the University of Texas at Austin. She is the Director for the Addictions Research Institute. Dr. Claborn received her Ph.D from Oklahoma State University and postdoctoral fellowship at Brown University’s Center for Alcohol and Addiction Studies. Her work focuses on identifying gaps in the healthcare system and strategies to use technology to improve the prevention and treatment of substance use disorders. Dr. Claborn has received over $10 million in extramural funding for her work from the National Institute of Health, SAMHSA, Health Resources and Services Administration, Google, and Texas Health and Human Services. She has received numerous awards for her innovative work in technology and addiction science, including being the recipient of a Google Cloud Services Award for building technology for social impact.
 
Disclosure: Dr. Claborn has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-9999-22-018-H04-P/T

Release Date: Mar 25, 2022
Credit Expiration Date: Mar 20, 2025

CE Hours

1.00
Registration Closed  

Registration Closed  

Pain Management: Pain Stewardship in the Hospital

Dan Arendt, Pharm.D., BCPS
Assistant Professor – Pain Stewardship
The James L. Winkle  College of Pharmacy
University of Cincinnati & UC Health
 
 
LEARNING OBJECTIVES
  • Describe the current state of the opioid overdose epidemic
  • Identify pain stewardship strategies that pharmacists can use to improve the quality of care that patients receive for both pain and substance use disorder.
  • Articulate how you as a practitioner can incorporate these strategies into your practice/heath system as a hospital professional.  

ABOUT THE FACULTY
 
Dr. Daniel Arendt (he/him) is an Assistant Professor of Pharmacy Practice and Administrative Sciences with a focus in Pain Management and Opioid Stewardship at the University of Cincinnati James L. Winkle College of Pharmacy. Within the college of pharmacy, he teaches pain management within the Therapeutics IV course in the third pharmacy professional year. He additionally coordinates clinical skills labs focused on pain management and serves on the PharmD admissions committee and the faculty development and recognition committee. In addition to his roles within the college, Dr. Arendt serves as the pain stewardship clinical pharmacy specialist at University of Cincinnati Medical Center. As the pain stewardship pharmacist for UCMC, he serves as a chair of the pain stewardship committee for UC Health, where he works to develop a system-wide pain stewardship program to optimize the practice of pain management and reduce opioid-related adverse events within not only the UC health system, but the greater Cincinnati community.  Dr. Arendt, originally from Buffalo, NY, earned both his Bachelor of Science in Pharmaceutical Sciences and his Doctor of Pharmacy degree from The University of Toledo. While in pharmacy school, he served on the Board of Trustees for the University and was involved in hiring Dr. Sharon Gaber, the first ever female president of the University of Toledo. After graduating from pharmacy school, Dr. Arendt completed a PGY-1 Pharmacy Residency and a combined Internal Medicine / Academia PGY-2 Pharmacy Residency at University Hospitals Geauga Medical Center and Northeast Ohio Medical University.  Dr. Arendt continues to be involved within AACP, ASHP and ACCP nationally. He additionally serves as the director-elect of legislative affairs for the Ohio Society of Health System Pharmacists. Locally he is a member of the Hamilton County Addiction Response Coalition, where he works to integrate the communities and universities response to the opioid overdose epidemic. He hopes to develop and study comprehensive strategies to limit the negative impacts of opioid use and combat the stigma surrounding addiction and mental health, all the while ensuring that pain patients have access to the proper medical that they need and deserve.
 
Disclosure: Dr. Arendt has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-22-055-H08-P/T

Release Date: Jun 9, 2022
Credit Expiration Date: Jun 8, 2025

CE Hours

1.25
Registration Closed  

Registration Closed  

Trauma-Informed Practice: Evolving from "What's Wrong" to "What's Happened"

 
K. Ashley Garling Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
President Capital Area Pharmacist Association
 
Kaitlin Berns, MPH, RD
Program Coordinator, Center for Health Communications
The University of Texas at Austin Moody College of Communications
 
Thea Woodruff, PhD
Project Coordinator, Well-being in Learning Environments
Counseling and Mental Health Center, University of Texas at Austin
 
 
LEARNING OBJECTIVES
  • Identify the types of trauma and the prevalence of trauma in the general population
  • Describe how trauma impacts individuals physiologically, psychologically, and emotionally
  • Recognize trauma response and indicators in patients, co-workers. And students in the healthcare setting
  • Demonstrate trauma-informed practice responses, reporting, and adaptions for accommodating trauma and trauma response
  • This activity may be counted as one hour of CPE for preceptor credit

ABOUT THE FACULTY
K. Ashley Garling Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
President Capital Area Pharmacist Association
 
Disclosure: Dr. Garling has no financial relationship(s) to disclose.
 
Kaitlin Berns, MPH, RD
Program Coordinator, Center for Health Communications
The University of Texas at Austin Moody College of Communications
 
Disclosure: Ms. Berns has no financial relationship(s) to disclose.
 
 
Thea Woodruff, PhD
Project Coordinator, Well-being in Learning Environments
Counseling and Mental Health Center, University of Texas at Austin
 
Disclosure: Dr. Woodruff has no financial relationship(s) to disclose.

Activity Number

0067-0000-22-057-H04-P/T

Release Date: Jun 9, 2022
Credit Expiration Date: Jun 8, 2025

CE Hours

1.00
Registration Closed  

Registration Closed  

Pharmacologic Treatments for Insomnia

 
Samantha Catanzano, PharmD, BCPP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 
 
 
LEARNING OBJECTIVES
  • Discuss the potential impact of insomnia on quality of life.  
  • Review pharmacologic treatments for insomnia.
  • Identify key differences in pharmacologic treatments for insomnia. 

ABOUT THE FACULTY
 
After graduating with her Pharm.D. degree from the University of Texas at Austin, Dr. Catanzano completed a pharmacy practice residency followed by a psychiatric pharmacy practice residency at Seton Healthcare Family and The University of Texas at Austin College of Pharmacy. Following her residency training, she gained experience as a clinical and staff pharmacist at the Austin State Hospital. Currently, she serves as a Clinical Assistant Professor for The University of Texas at Austin College of Pharmacy. She also provides academic lectures to first- and second-year psychiatry residents and addiction medicine fellows through Dell Medical School’s department of psychiatry. In addition to her academic appointment, she is a Psychiatric Pharmacist at UT Health Austin within the Integrated Behavioral Health Department where she serves the Primary Care, Musculoskeletal, Post-COVID-19 Program, and Multiple Sclerosis clinics. In this role, she functions as part of a multidisciplinary team to address complex pharmacology and mental health needs in the community setting. Additionally, she is a certified Mental Health First Aid instructor and is an active leader within the American Association of Psychiatric Pharmacists (AAPP).

Disclosure: Dr. Catanzano has no financial relationship(s) to disclose.


Activity Number

0067-0000-22-068-H01-P

Release Date: Sep 24, 2022
Credit Expiration Date: Sep 23, 2025

CE Hours

1.00
Registration Closed  

Registration Closed  

A Systems Approach to Clinician Well-Being

 

M. Lynn Crismon, PharmD, FCCP, DABCP, BCPP
Behrens Centennial Professor of Pharmacy
The University of Texas at Austin College of Pharmacy
 
 
LEARNING OBJECTIVES
  • Identify symptoms of burnout and how they make affect behavior in the workplace.
  • Discuss system issues in pharmacy and healthcare that contribute to burnout.
  • Recommend changes in pharmacy and healthcare systems that would improve clinician well-being.
  • Summarize the key points in the National Academy of Medicine’s National Plan for Health Workforce Well-being.
  • Commit to at least one change that you can make in your workplace to decrease the risk of burnout and improve well-being among pharmacists and other pharmacy personnel.

ABOUT THE FACULTY
 

M. Lynn Crismon is the Behrens Centennial Professor of Pharmacy and Professor of Psychiatry at The University of Texas at Austin and past Dean and James T. Doluisio Regents Chair of the
College of Pharmacy. He is board certified in psychiatric pharmacy and a Diplomate of the American Board of Clinical Pharmacology. His research has focused on improving the pharmacotherapy of severe mental disorders and mental health outcomes research. He has 268 publications and over 207 abstracts. He has supervised 39 psychiatric pharmacy residents, research fellows, or graduate students. He is a founding steering committee member and faculty member in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives. He is a recipient of the ACCP Paul F. Parker Medal and the ASHP Board of Directors Distinguished Leadership Award.

Disclosure:   Lynn Crismon does not have any relevant financial relationship(s) with ineligible companies

Activity Number

0067-0000-22-064-H05-P

Release Date: Sep 24, 2022
Credit Expiration Date: Sep 22, 2025

CE Hours

1.00
Registration Closed  

Registration Closed  

Deprescribing to Improve Patient Care and Quality of Life

 

Sara Rogers, PharmD
Director of Clinical Affairs
American Society of Pharmacovigilance
 
 
LEARNING OBJECTIVES
  • Explain deprescribing and its purpose in practice. 
  • Identify which patients and medications are good candidates for deprescribing. 
  • Discuss the stepwise approach to safe and effective deprescribing.
  • Recommend useful resources and evidence-based algorithms as guidance for successful deprescribing practices.

ABOUT THE FACULTY
 

Sara Rogers serves as Clinical Assistant Professor of Precision Medicine and Ambulatory Care at Irma Lerma Rangel College of Pharmacy, Texas A&M University and Clinical Specialist at Texas A&M Physicians Clinic. She co-founded the American Society of Pharmacovigilance, where she led the Society’s clinical, research and educational initiatives. Rogers co-led the formation of the Pharmacogenomics Access and Reimbursement Coalition and collaboratively developed the Coalition’s research agenda to understand the payment and policy landscape for pharmacogenetics testing and its role in disparities in patient access. Rogers serves as an organizational member of the NIH National Human Genomics Research Institute Inter-Society Coordinating Committee and develops educational resources to help practitioners navigate coverage for pharmacogenetics testing. Her research track record reveals a long-standing goal of informing policy and practice. Dr. Rogers has served as co-investigator for a pilot study to identify ethical values and priorities related to pharmacogenomics. Her research focuses extensively on patient access to and reimbursement for pharmacogenetics testing. Rogers co-led the formation of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, a public-private multidisciplinary initiative to develop consensus-based industry standards for pharmacogenetics testing.  Prior to serving in these roles, Rogers was an Ambulatory Treatment Center pharmacist at MD Anderson Cancer Center where she led team-based research projects to optimize workflow and screening protocols throughout the division of pharmacy.

Disclosure:  Sara Rogers does not have any relevant financial relationship(s) with ineligible companies

Activity Number

0067-0000-22-069-H04-P

Release Date: Sep 24, 2022
Credit Expiration Date: Sep 22, 2025

CE Hours

1.00
Registration Closed  

Registration Closed  

Please visit our virtual exhibitors below!

 

 

Open the tabs below to view our virtual exhibit tables with links and information on their products.

 
 
Want to exhibit in-person and/or virtually in this space?  Contact Glen Baumgart at gbaumgart@austin.utexas.edu for more information

Registration Closed  

Registration Closed  

Thank you for taking the time to learn more about our treatment options.

Alkermes seeks to develop medicines that help address the unmet needs and challenges of people living with debilitating diseases. As a fully-integrated, global biopharmaceutical company, Alkermes applies its scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference in the way patients manage their disease.

This page is intended for US Healthcare Professional audiences only.
 
For more information, contact us here: https://landing.alkermes.info/34th-Psychiatric-Pharmacotherapy-Update.html

Learn more about treatment options for:
 
 
 

Registration Closed  

Registration Closed  

Exhibitor: Abbvie

 

Thank you Abbvie for supporting the 34th Psychiatric Pharmacotherapy Update

 
 

Contact:

John Alexander

Sales Representative, CNS 

Psychiatry, Austin, TX

 

CELL  737-346-7863

EMAIL  John.alexander@abbvie.com

Registration Closed  

Registration Closed  

Exhibitor: BioXcel Therapeutics, Inc.

 

Thank you BioXcel Therapeutics for supporting the 34th Psychiatric Pharmacotherapy Update

 
 
 

Bob Malloy

Institutional Specialist Mobile: (214) 796-6489

bmalloy@bioxceltherapeutics.com 

Registration Closed  

Registration Closed  

Exhibitor: UTMB - Correctional Managed Care

 

Thank you UTMB for supporting the 34th Psychiatric Pharmacotherapy Update

 

Employment:  Correctional Managed Care


We're glad you stopped by and hope that you aspire to become part of the CMC family. UTMB CMC employs a diverse workforce committed to service, education, community, and innovation.

Applicants interested in applying for jobs within Correctional Managed Care should click on http://www.utmb.edu/careers/. Please contact Kevin Martin, Sr. Recruiter/Human Resources - Correctional Managed Care (CMC) at 409-747-2694 or kelmarti@utmb.edu.

The future looks promising for UTMB Correctional Managed Care Employees. UTMB Correctional Managed Care is a unique place to operate as a health professional, offering you the opportunity to work in a stimulating, independent and multifaceted workplace. Our health care system redevelopment offers valuable and timely experience in innovative care while providing opportunities in clinic management.

As a UTMB Correctional Managed Care employee, you are a member of a premier health care network that currently includes over 3,100 employees serving 110,000 patients. Not only will you be exposed to a managed care environment, you will be critical to its success. Your efforts will be valued, respected, and recognized.

 

Contact:

Kevin Martin

Sr. Recruiter/Human Resources– Correctional Managed Care (CMC)

1560 W. Bay Area Blvd. Ste. 100 Friendswood, Tx 77546

P 409-747-2694  F 409-763-1915  E Kelmarti@utmb.edu

University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas  77555-1206

Registration Closed  

Registration Closed  

 
 
 
 

Report an overdose

All information is anonymous and does not trace back to a specific person. Your report can help save lives.

 

Project Goals

The goal of this community-centered project is to develop a robust digital platform that aggregates data to drive community response efforts to the overdose crisis in Texas.

Visit the Website

TxCOPE: https://txcope.org/

Project CONNECT: https://projectconnecttx.org/

Why It’s Needed

  • Texas needs better data to improve access to substance use treatment, overdose prevention, and harm reduction services.
  • This tool will help our community-based organizations and public health agencies better serve our communities through data-driven resource allocation and outreach.
  • This website and mobile application is the safe way in Texas to report an overdose and help save lives.

Contact Us
 
 

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed  

Registration Closed